OrthoPediatrics (KIDS) Competitors $21.54 -0.22 (-1.01%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$21.57 +0.03 (+0.14%) As of 04/25/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KIDS vs. LMAT, LIVN, ENOV, NVCR, CNMD, WRBY, CDRE, KMTS, PLSE, and LQDAShould you be buying OrthoPediatrics stock or one of its competitors? The main competitors of OrthoPediatrics include LeMaitre Vascular (LMAT), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), CONMED (CNMD), Warby Parker (WRBY), Cadre (CDRE), Kestra Medical Technologies (KMTS), Pulse Biosciences (PLSE), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. OrthoPediatrics vs. LeMaitre Vascular LivaNova Enovis NovoCure CONMED Warby Parker Cadre Kestra Medical Technologies Pulse Biosciences Liquidia LeMaitre Vascular (NASDAQ:LMAT) and OrthoPediatrics (NASDAQ:KIDS) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, community ranking, dividends, media sentiment, institutional ownership and valuation. Do insiders & institutionals have more ownership in LMAT or KIDS? 84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 10.8% of LeMaitre Vascular shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher valuation & earnings, LMAT or KIDS? LeMaitre Vascular has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLeMaitre Vascular$219.86M9.40$30.10M$1.9447.22OrthoPediatrics$204.73M2.56-$20.97M-$1.63-13.21 Which has more volatility & risk, LMAT or KIDS? LeMaitre Vascular has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500. Does the MarketBeat Community prefer LMAT or KIDS? LeMaitre Vascular received 200 more outperform votes than OrthoPediatrics when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 64.42% of users gave OrthoPediatrics an outperform vote. CompanyUnderperformOutperformLeMaitre VascularOutperform Votes51570.45% Underperform Votes21629.55% OrthoPediatricsOutperform Votes31564.42% Underperform Votes17435.58% Do analysts prefer LMAT or KIDS? LeMaitre Vascular currently has a consensus price target of $98.14, suggesting a potential upside of 7.13%. OrthoPediatrics has a consensus price target of $37.00, suggesting a potential upside of 71.77%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts plainly believe OrthoPediatrics is more favorable than LeMaitre Vascular.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LeMaitre Vascular 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.63OrthoPediatrics 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is LMAT or KIDS more profitable? LeMaitre Vascular has a net margin of 19.40% compared to OrthoPediatrics' net margin of -15.00%. LeMaitre Vascular's return on equity of 13.15% beat OrthoPediatrics' return on equity.Company Net Margins Return on Equity Return on Assets LeMaitre Vascular19.40% 13.15% 11.47% OrthoPediatrics -15.00%-5.78%-4.80% Does the media favor LMAT or KIDS? In the previous week, LeMaitre Vascular had 8 more articles in the media than OrthoPediatrics. MarketBeat recorded 9 mentions for LeMaitre Vascular and 1 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.71 beat LeMaitre Vascular's score of 1.30 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Overall Sentiment LeMaitre Vascular Positive OrthoPediatrics Very Positive SummaryLeMaitre Vascular beats OrthoPediatrics on 13 of the 19 factors compared between the two stocks. Get OrthoPediatrics News Delivered to You Automatically Sign up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KIDS vs. The Competition Export to ExcelMetricOrthoPediatricsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$523.14M$4.29B$5.44B$7.80BDividend YieldN/A46.48%5.43%4.30%P/E Ratio-17.5130.2922.1418.40Price / Sales2.5652.52389.70101.29Price / CashN/A51.0838.2034.62Price / Book1.336.096.664.18Net Income-$20.97M$67.60M$3.21B$247.71M7 Day Performance2.57%4.51%6.16%6.56%1 Month Performance-11.76%-7.02%-2.86%-2.25%1 Year Performance-28.82%27.14%16.43%4.67% OrthoPediatrics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KIDSOrthoPediatrics4.4626 of 5 stars$21.54-1.0%$37.00+71.8%-28.1%$523.14M$204.73M-17.51200LMATLeMaitre Vascular2.26 of 5 stars$84.72-1.8%$95.25+12.4%+45.4%$1.91B$219.86M46.30490Upcoming EarningsPositive NewsLIVNLivaNova3.6898 of 5 stars$34.61-2.7%$61.17+76.7%-32.4%$1.88B$1.25B82.402,900Upcoming EarningsNews CoveragePositive NewsENOVEnovis2.6905 of 5 stars$32.25+0.9%$58.50+81.4%-36.4%$1.84B$2.11B-14.736,800News CoveragePositive NewsNVCRNovoCure3.6763 of 5 stars$15.58flat$34.17+119.3%+51.3%$1.71B$605.22M-11.131,320Earnings ReportAnalyst ForecastNews CoverageCNMDCONMED4.5896 of 5 stars$47.71-1.8%$77.20+61.8%-18.1%$1.48B$1.31B11.254,100Upcoming EarningsWRBYWarby Parker3.7057 of 5 stars$14.09-1.2%$23.50+66.8%+21.6%$1.46B$771.32M-52.193,030Analyst ForecastNews CoverageCDRECadre3.0049 of 5 stars$29.16-5.1%$37.00+26.9%-7.6%$1.18B$567.56M35.132,240Dividend AnnouncementNews CoverageKMTSKestra Medical TechnologiesN/A$23.54-3.9%$27.50+16.8%N/A$1.17B$45.82M0.00300PLSEPulse Biosciences1.2363 of 5 stars$17.29-2.5%N/A+167.7%$1.16B$700,000.000.00140News CoverageLQDALiquidia2.8063 of 5 stars$13.29-3.1%$26.63+100.3%+14.1%$1.13B$14.00M-8.1550News CoveragePositive News Related Companies and Tools Related Companies LMAT Competitors LIVN Competitors ENOV Competitors NVCR Competitors CNMD Competitors WRBY Competitors CDRE Competitors KMTS Competitors PLSE Competitors LQDA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KIDS) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KIDS Stock Free KIDS Stock Alerts